Front. Vet. Sci.
Frontiers in Veterinary Science
Front. Vet. Sci.
2297-1769
Frontiers Media S.A.
10.3389/fvets.2023.1136968
Veterinary Science
Erratum
Erratum: Pharmacokinetic studies in elasmobranchs: Meloxicam administered at 0.5 mg/kg using intravenous, intramuscular, and oral routes to nursehound sharks (Scyliorhinus stellaris)
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Production Office ✉ production.office@frontiersin.org
This article was submitted to Veterinary Pharmacology and Toxicology, a section of the journal Frontiers in Veterinary Science
18
01
2023
2023
10
1136968
03
01
2023
03
01
2023
Copyright © 2023 Frontiers Production Office.
2023
Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Erratum on Pharmacokinetic studies in elasmobranchs: Meloxicam administered at 0.5 mg/kg using intravenous, intramuscular, and oral routes to nursehound sharks (Scyliorhinus stellaris) by Morón-Elorza, P., Rojo-Solís, C., Álvaro-Álvarez, T., Valls-Torres, M., García-Párraga, D., and Encinas, T. (2022). Front. Vet. Sci. 9:845555. doi: 10.3389/fvets.2022.845555
meloxicam
shark
chondrichthyan
pharmacology
pharmacokinetics
non-steroidal anti-inflammatory drug (NSAID)
half-life (T1/2)
Due to a production error, there was a spelling error in the title “Pharmacokinetic Studies in Elasmobranchs: Meloxicam Administered at 0.5 mg/kg Using Intravenous, Intramuscular, and Oral Routes to Nusehound Sharks (Scyliorhinus stellaris)”. The correct title is “Pharmacokinetic Studies in Elasmobranchs: Meloxicam Administered at 0.5 mg/kg Using Intravenous, Intramuscular, and Oral Routes to Nursehound Sharks (Scyliorhinus stellaris)”.
The publisher apologizes for this mistake. The original version of this article has been updated.